Non-Hodgkin lymphoma and autoimmunity: Does gender matter?
Corresponding Author
Pat Ansell
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Tel.: +44(0)1904321890, Fax: +44(0)1904321899
Epidemiology and Genetics Unit, Department of Health Sciences, Seebohm Rowntree Building, University of York, York YO10 5DD, United KingdomSearch for more papers by this authorJill Simpson
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorTracy Lightfoot
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorAlex Smith
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorEleanor Kane
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorDebra Howell
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorRob Newton
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorDennis McGonagle
Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom
Search for more papers by this authorAndrew Jack
Haematological Malignancy Diagnostic Service, St James's Institute of Oncology, Bexley Wing, St James's University Hospital, Leeds, United Kingdom
Search for more papers by this authorEve Roman
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorCorresponding Author
Pat Ansell
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Tel.: +44(0)1904321890, Fax: +44(0)1904321899
Epidemiology and Genetics Unit, Department of Health Sciences, Seebohm Rowntree Building, University of York, York YO10 5DD, United KingdomSearch for more papers by this authorJill Simpson
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorTracy Lightfoot
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorAlex Smith
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorEleanor Kane
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorDebra Howell
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorRob Newton
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorDennis McGonagle
Section of Musculoskeletal Disease, Leeds Institute of Molecular Medicine, University of Leeds, Leeds, United Kingdom
Search for more papers by this authorAndrew Jack
Haematological Malignancy Diagnostic Service, St James's Institute of Oncology, Bexley Wing, St James's University Hospital, Leeds, United Kingdom
Search for more papers by this authorEve Roman
Epidemiology and Genetics Unit, Department of Health Sciences, University of York, York, United Kingdom
Search for more papers by this authorAbstract
Autoimmune disorders are more frequent in women, whereas most non-Hodgkin lymphomas (NHLs) are common in men; yet, sex-specific autoimmune–lymphoma associations are rarely reported. Detailed data on autoimmune disease were abstracted from medical records of 791 cases (including 316 diffuse large B-cell lymphomas (DLBCLs); 228 follicular lymphomas (FLs); 127 marginal zone lymphomas (MZLs); 64 T-cell lymphomas and 38 mantle cell lymphomas) and 872 controls. The combined prevalence of autoimmune disease was higher among women (15.7% controls; 19.7% cases) than men (6.6% controls; 14.5% cases), but the overall association with NHL was stronger for men (odds ratio 2.4, 95% confidence interval: 1.5–3.8) than women (1.3, 0.9–1.9), the disparity persisting when data for the year immediately preceding lymphoma diagnosis were excluded (men 2.0, 1.3–3.3; women 1.2, 0.8–1.8). For both sexes, the strongest individual associations were for DLBCL, MZL and T-cell lymphomas, with no associations evident for FL. Among women, there were strong links between MZL and both Sjögren's syndrome and idiopathic thrombocytopenia, and among men, between DLBCL and both rheumatoid arthritis and Crohn's disease. The expected association between coeliac disease and T-cell lymphoma was seen in both sexes. Our results add to the accumulating knowledge on this topic and suggest that future studies should analyze data for men and women separately.
References
- 1 Goldin LR, Landgren O. Autoimmunity and lymphomagenesis. Int J Cancer 2009; 124: 1497–502.
- 2 Anderson LA, Gadalla S, Morton LM, Landgren O, Pfeiffer R, Warren JL, Berndt SI, Ricker W, Parsons R, Engels EA. Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies. Int J Cancer 2009; 125: 398–405.
- 3 Smedby KE, Askling J, Mariette X, Baecklund E. Autoimmune and inflammatory disorders and risk of malignant lymphomas—an update. J Intern Med 2008; 264: 514–27.
- 4 Hansen A, Lipsky PE, Dorner T. B-cell lymphoproliferation in chronic inflammatory rheumatic diseases. Nat Clin Pract Rheumatol 2007; 3: 561–9.
- 5 Kovacs L, Szodoray P, Kiss E. Secondary tumours in Sjogren's syndrome. Autoimmun Rev 2010; 9: 203–6.
- 6 Ekstrom SK, Vajdic CM, Falster M, Engels EA, Martinez-Maza O, Turner J, Hjalgrim H, Vineis P, Seniori CA, Bracci PM, Holly EA, Willett E, et al. Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood 2008; 111: 4029–38.
- 7 Franklin J, Lunt M, Bunn D, Symmons D, Silman A. Incidence of lymphoma in a large primary care derived cohort of cases of inflammatory polyarthritis. Ann Rheum Dis 2006; 65: 617–22.
- 8 Kiss E, Kovacs L, Szodoray P. Malignancies in systemic lupus erythematosus. Autoimmun Rev 2010; 9: 195–9.
- 9 Tack GJ, Verbeek WH, Schreurs MW, Mulder CJ. The spectrum of celiac disease: epidemiology, clinical aspects and treatment. Nat Rev Gastroenterol Hepatol 2010; 7: 204–13.
- 10 Mackay IR, Rose NR. Autoimmunity and lymphoma: tribulations of B cells. Nat Immunol 2001; 2: 793–5.
- 11 Kristinsson SY, Goldin LR, Bjorkholm M, Koshiol J, Turesson I, Landgren O. Genetic and immune-related factors in the pathogenesis of lymphoproliferative and plasma cell malignancies. Haematologica 2009; 94: 1581–9.
- 12 Hellgren K, Smedby KE, Feltelius N, Baecklund E, Askling J. Do rheumatoid arthritis and lymphoma share risk factors?: a comparison of lymphoma and cancer risks before and after diagnosis of rheumatoid arthritis. Arthritis Rheum 2010; 62: 1252–8.
- 13 Schuetz C, Niehues T, Friedrich W, Schwarz K. Autoimmunity, autoinflammation and lymphoma in combined immunodeficiency (CID). Autoimmun Rev 2010; 9: 477–82.
- 14 Invernizzi P, Pasini S, Selmi C, Gershwin ME, Podda M. Female predominance and X chromosome defects in autoimmune diseases. J Autoimmun 2009; 33: 12–16.
- 15 Gleicher N, Barad DH. Gender as risk factor for autoimmune diseases. J Autoimmun 2007; 28: 1–6.
- 16 Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 2008; 173: 600–9.
- 17 Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009; 59: 225–49.
- 18 Smith A, Roman E, Howell D, Jones R, Patmore R, Jack A. The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol 2010; 148: 739–53.
- 19 World Health Organization. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer, 2008.
- 20 Bird MD, Karavitis J, Kovacs EJ. Sex differences and estrogen modulation of the cellular immune response after injury. Cell Immunol 2008; 252: 57–67.
- 21 Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007; 6: 366–72.
- 22 Fish EN. The X-files in immunity: sex-based differences predispose immune responses. Nat Rev Immunol 2008; 8: 737–44.
- 23 Mellemkjaer L, Linet MS, Gridley G, Frisch M, Moller H, Olsen JH. Rheumatoid arthritis and cancer risk. Eur J Cancer 1996; 32A: 1753–7.
- 24 Yamada T, Nakajima A, Inoue E, Tanaka E, Taniguchi A, Momohara S, Yamanaka H. Incidence of malignancy in Japanese patients with rheumatoid arthritis. Rheumatol Int, in press. DOI: 10.1007/s00296-010-1524-0.
- 25 Zintzaras E, Voulgarelis M, Moutsopoulos HM. The risk of lymphoma development in autoimmune diseases: a meta-analysis. Arch Intern Med 2005; 165: 2337–44.
- 26 Gridley G, McLaughlin JK, Ekbom A, Klareskog L, Adami HO, Hacker DG, Hoover R, Fraumeni JF, Jr. Incidence of cancer among patients with rheumatoid arthritis. J Natl Cancer Inst 1993; 85: 307–11.
- 27 Mellemkjaer L, Pfeiffer RM, Engels EA, Gridley G, Wheeler W, Hemminki K, Olsen JH, Dreyer L, Linet MS, Goldin LR, Landgren O. Autoimmune disease in individuals and close family members and susceptibility to non-Hodgkin's lymphoma. Arthritis Rheum 2008; 58: 657–66.
- 28 Smedby KE, Hjalgrim H, Askling J, Chang ET, Gregersen H, Porwit-MacDonald A, Sundstrom C, Akerman M, Melbye M, Glimelius B, Adami HO. Autoimmune and chronic inflammatory disorders and risk of non-Hodgkin lymphoma by subtype. J Natl Cancer Inst 2006; 98: 51–60.
- 29 Willett EV, Smith AG, Dovey GJ, Morgan GJ, Parker J, Roman E. Tobacco and alcohol consumption and the risk of non-Hodgkin lymphoma. Cancer Causes Control 2004; 15: 771–80.
- 30 Newton R, Crouch S, Ansell P, Simpson J, Willett EV, Smith A, Burton C, Jack A, Roman E. Hodgkin's lymphoma and infection: findings from a UK case-control study. Br J Cancer 2007; 97: 1310–14.
- 31 World Health Organization. Tumours of haematopoietic and lymphoid tissues. Lyon: World Health Organization, 2001.
- 32 World Health Organization. International statistical classification of diseases and health related problems. Geneva: World Health Organization, 1992.
- 33 British Medical Association RPSoGB. British National Formulary—Number 24 (September). London: British Medical Association and The Pharmaceutical Press, 1992.
- 34 McGonagle D, McDermott MF. A proposed classification of the immunological diseases. PLoS Med 2006; 3: e297.
- 35 Soderberg KC, Jonsson F, Winqvist O, Hagmar L, Feychting M. Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden. Eur J Cancer 2006; 42: 3028–33.
- 36 Provan D, Stasi R, Newland AC, Blanchette VS, Bolton-Maggs P, Bussel JB, Chong BH, Cines DB, Gernsheimer TB, Godeau B, Grainger J, Greer I, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood 2010; 115: 168–86.
- 37 Grant SF, Hakonarson H, Schwartz S. Can the genetics of type 1 and type 2 diabetes shed light on the genetics of latent autoimmune diabetes in adults? Endocr Rev 2010; 31: 183–93.
- 38 StataCorp LP. Stata/IC 10.1 for Windows [computer program]. College Station, TX: StataCorp LP, 2007.